What are the causes of poikilocytosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Causes of Poikilocytosis

Poikilocytosis (abnormal red blood cell shapes) occurs in a broad spectrum of hematologic disorders, most commonly hereditary hemolytic anemias (red cell enzyme deficiencies, membrane disorders, unstable hemoglobins), congenital dyserythropoietic anemias, severe nutritional deficiencies (iron, B12, folate), myelodysplastic syndromes, and advanced malignancies.

Primary Hematologic Causes

Hereditary Hemolytic Anemias

The most characteristic causes include:

  • Red cell enzyme deficiencies (e.g., pyruvate kinase deficiency): Generally display "some degree of anisocytosis and poikilocytosis" with 3-30% echinocytes, particularly after splenectomy 1
  • Red cell membrane disorders (e.g., hereditary pyropoikilocytosis, hereditary spherocytosis): Present with marked poikilocytosis from birth, often requiring exchange transfusions or phototherapy in neonates 2
  • Unstable hemoglobins and thalassemias: Produce variable poikilocytosis patterns 1
  • Congenital dyserythropoietic anemias: Share overlapping features with enzyme deficiencies 1

Nutritional Deficiencies

Iron deficiency is the most common cause of microcytic anemia with poikilocytosis:

  • Confirmed by ferritin <30 ng/mL (without inflammation) or <100 ng/mL (with inflammation) 3
  • Transferrin saturation <15% supports the diagnosis 4
  • Look for sources of blood loss (GI bleeding, menstruation) 4

Vitamin B12 deficiency causes marked poikilocytosis that can mimic schistocytosis:

  • Presents with macrocytic anemia, elevated LDH (often >2500 IU/L), and low reticulocyte count (key distinguishing feature from hemolysis) 5
  • B12 <50 pg/mL with elevated methylmalonic acid confirms diagnosis 5
  • Critical pitfall: Can present as "pseudothrombotic microangiopathy" with thrombocytopenia and schistocyte-like cells, potentially leading to misdiagnosis as TTP 5

Folate deficiency produces similar megaloblastic changes with poikilocytosis 6, 3

Myelodysplastic Syndromes

MDS commonly presents with poikilocytosis alongside other dysplastic features:

  • Requires bone marrow examination showing >10% dysplastic cells in affected lineages 7
  • Peripheral smear shows anisocytosis, poikilocytosis, and variable blast counts 7
  • Cytogenetic analysis is mandatory for diagnosis 7

Secondary Causes

Malignancy

Poikilocytosis occurs in 12% of cancer patients, particularly:

  • Adenocarcinoma of the gastrointestinal tract (most common) 8
  • Inoperable metastatic carcinoma 8
  • Prognostic significance: 50% of cancer patients with poikilocytosis died within one month versus 21% without poikilocytosis 8
  • Can occur without anemia or uremia 8

Chronic Disease States

  • Anemia of chronic inflammation: Produces normocytic or microcytic anemia with mild poikilocytosis 4
  • Renal disease: GFR <60 mL/min/1.73 m² with low erythropoietin 4
  • Hepatic disease: Associated with spiculated cells (acanthocytes) 9
  • Hemolysis: Elevated LDH, low haptoglobin, positive Coombs test, elevated indirect bilirubin 4

Diagnostic Algorithm

When encountering poikilocytosis:

  1. Assess MCV to categorize anemia type 4:

    • Microcytic (<80 fL): Iron deficiency, thalassemia, chronic disease, sideroblastic anemia
    • Normocytic (80-100 fL): Hemorrhage, hemolysis, bone marrow failure, chronic inflammation
    • Macrocytic (>100 fL): B12/folate deficiency, MDS, medications (hydroxyurea)
  2. Check reticulocyte index 4:

    • Low (decreased production): Nutritional deficiencies, aplastic anemia, bone marrow dysfunction
    • High (increased production): Blood loss or hemolysis
  3. Iron studies 3:

    • Ferritin, transferrin saturation, TIBC
    • Consider CRP if inflammation suspected (elevates ferritin independently)
  4. If macrocytic with poikilocytosis: Check B12, folate, methylmalonic acid 5

    • Never give folate before excluding B12 deficiency (risk of subacute combined degeneration) 6
  5. If unexplained chronic hemolysis: Consider hereditary disorders after excluding immune-mediated process, membrane defects, unstable hemoglobin, and PNH 1

Critical Clinical Pitfalls

  • B12 deficiency mimicking TTP: Look for low reticulocyte count and extremely elevated LDH (>2500 IU/L) to distinguish from true microangiopathy 5
  • Ferritin interpretation in inflammation: Levels up to 100 μg/L may still indicate iron deficiency when inflammation is present 3
  • Neonatal poikilocytosis: Marked poikilocytosis with hyperbilirubinemia requiring therapy warrants red cell membrane analysis if conventional workup is negative 2
  • Cancer patients: Poikilocytosis carries poor prognosis even without anemia 8

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.